Intelligent Bio Solutions Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名192/404位。机构持股占比非常高,近一月多位分析师给出公司评级为。最高目标价12.00。中期看,股价处于上升通道。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。
Intelligent Bio Solutions Inc评分
相关信息
行业排名
192 / 404
全市场排名
343 / 4582
所属行业
生物技术与医疗研究
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
0
位分析师
--
评级
12.000
目标均价
+455.56%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
Intelligent Bio Solutions Inc亮点
亮点风险
Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
公司代码INBS
公司Intelligent Bio Solutions Inc
CEOSimeonidis (Harry)
网址https://ibs.inc/
常见问题
Intelligent Bio Solutions Inc(INBS)的当前股价是多少?
Intelligent Bio Solutions Inc(INBS)的当前股价是 6.140。
Intelligent Bio Solutions Inc的股票代码是什么?
Intelligent Bio Solutions Inc的股票代码是INBS。
Intelligent Bio Solutions Inc股票的52周最高点是多少?
Intelligent Bio Solutions Inc股票的52周最高点是27.500。
Intelligent Bio Solutions Inc股票的52周最低点是多少?
Intelligent Bio Solutions Inc股票的52周最低点是5.091。
Intelligent Bio Solutions Inc的市值是多少?
Intelligent Bio Solutions Inc的市值是55.86M。
Intelligent Bio Solutions Inc的净利润是多少?
Intelligent Bio Solutions Inc的净利润为-10.57M。
现在Intelligent Bio Solutions Inc(INBS)的股票是买入、持有还是卖出?
根据分析师评级,Intelligent Bio Solutions Inc(INBS)的总体评级为--,目标价格为12.000。
Intelligent Bio Solutions Inc(INBS)股票的每股收益(EPS TTM)是多少
Intelligent Bio Solutions Inc(INBS)股票的每股收益(EPS TTM)是-1.648。